Non-inferiority trials are a valuable type of clinical trial to evaluate new treatments that might have differing benefits. Such trials are increasingly used, but have methodological challenges in ...
AMRMX is the $113bn American Mutual Fund, AIVSX is the $178bn Investment Company of America, AMCPX is the $96bn AMCAP Fund, ANWPX is the $165bn New Perspective Fund, and AGTHX is the titanic $336bn ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results